Literature DB >> 11418881

Vancomycin-resistant enterococci: mechanisms and clinical observations.

H S Gold1.   

Abstract

Enterococci are not generally regarded as highly virulent bacterial pathogens. However, resistance to many antimicrobial drugs complicates treatment of enterococcal infections. Acquired resistance to high concentrations of glycopeptide antibiotics, specifically vancomycin, has exacerbated this problem. This article seeks to concisely review the mechanisms of that resistance and its effects on clinical management of enterococcal infections, as well as clinical microbiology and infection control.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11418881     DOI： 10.1086/321815

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  56 in total

Review 1.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Evaluation of a rapid direct assay for identification of bacteria and the mec A and van genes from positive-testing blood cultures.

Authors:  U Eigner; M Weizenegger; A-M Fahr; W Witte
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Evaluation of a new molecular system for simultaneous identification of four Enterococcus species and their glycopeptide resistance genotypes.

Authors:  U Eigner; A Fahr; M Weizenegger; W Witte
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 4.  Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.

Authors:  I Klare; C Konstabel; S Mueller-Bertling; G Werner; B Strommenger; C Kettlitz; S Borgmann; B Schulte; D Jonas; A Serr; A M Fahr; U Eigner; W Witte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

5.  Enterococcus faecium low-affinity pbp5 is a transferable determinant.

Authors:  Louis B Rice; Lenore L Carias; Susan Rudin; Viera Lakticová; Aaron Wood; Rebecca Hutton-Thomas
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 6.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

7.  Development of a panel of recombinase polymerase amplification assays for detection of common bacterial urinary tract infection pathogens.

Authors:  B Raja; H J Goux; A Marapadaga; S Rajagopalan; K Kourentzi; R C Willson
Journal:  J Appl Microbiol       Date:  2017-08       Impact factor: 3.772

8.  Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice.

Authors:  Costi D Sifri; Eleftherios Mylonakis; Kavindra V Singh; Xiang Qin; Danielle A Garsin; Barbara E Murray; Frederick M Ausubel; Stephen B Calderwood
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Synthesis and binding studies of two new macrocyclic receptors for the stereoselective recognition of dipeptides.

Authors:  Ana Maria Castilla; M Morgan Conn; Pablo Ballester
Journal:  Beilstein J Org Chem       Date:  2010-01-19       Impact factor: 2.883

10.  Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.

Authors:  Young-Bem Se; Hyoung-Joon Chun; Hyeong-Joong Yi; Dong-Won Kim; Yong Ko; Suck-Jun Oh
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.